Biogen Netherlands News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Treatments for amyotrophic lateral sclerosis and paroxysmal nocturnal hemoglobinuria have been given marketing authorization by the European Medicines Agency.

European medicines agencyCommittee for medicinal products human useEuropean unionNew england journalMedicinal productsHuman useBiogen netherlandsNocturnal hemoglubinuriaGenomics genomic medicineWorld medicineForeign medicineInternational medicineGlobal medicineInternational practice of medicineMedical innovationsNnovations in medicine